-
Something wrong with this record ?
ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas
B. Pokrývková, J. Šmahelová, N. Dalewská, M. Grega, O. Vencálek, M. Šmahel, J. Nunvář, J. Klozar, R. Tachezy
Language English Country Switzerland
Document type Journal Article
Grant support
CZ.1.05/2.1.00/19.0400
European Regional Development Fund
CZ.02.1.01/0.0/0.0/16_019/0000785
European Regional Development Fund
17-28055A
Czech Health Research Council
1502118
Charles University Grant Agency
260568
Charles University Specific University Research
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- Publication type
- Journal Article MeSH
Head and neck squamous cell carcinomas (HNSCC) can be induced by smoking or alcohol consumption, but a growing part of cases relate to a persistent high-risk papillomavirus (HPV) infection. Viral etiology has a beneficial impact on the prognosis, which may be explained by a specific immune response. Tumor associated macrophages (TAMs) represent the main immune population of the tumor microenvironment with a controversial influence on the prognosis. In this study, the level, phenotype, and spatial distribution of TAMs were evaluated, and the expression of TAM-associated markers was compared in HPV positive (HPV+) and HPV negative (HPV-) tumors. Seventy-three formalin and embedded in paraffin (FFPE) tumor specimens were examined using multispectral immunohistochemistry for the detection of TAM subpopulations in the tumor parenchyma and stroma. Moreover, the mRNA expression of TAM markers was evaluated using RT-qPCR. Results were compared with respect to tumor etiology, and the prognostic significance was evaluated. In HPV- tumors, we observed more pro-tumorigenic M2 in the stroma and a non-macrophage arginase 1 (ARG1)-expressing population in both compartments. Moreover, higher mRNA expression of M2 markers-cluster of differentiation 163 (CD163), ARG1, and prostaglandin-endoperoxide synthase 2 (PTGS2)-was detected in HPV- patients, and of M1 marker nitric oxide synthase 2 (NOS2) in HPV+ group. The expression of ARG1 mRNA was revealed as a negative prognostic factor for overall survival of HNSCC patients.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018052
- 003
- CZ-PrNML
- 005
- 20210729104116.0
- 007
- ta
- 008
- 210726s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/diagnostics11040628 $2 doi
- 035 __
- $a (PubMed)33807310
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Pokrývková, Barbora $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 252 50 Vestec, Czech Republic
- 245 10
- $a ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas / $c B. Pokrývková, J. Šmahelová, N. Dalewská, M. Grega, O. Vencálek, M. Šmahel, J. Nunvář, J. Klozar, R. Tachezy
- 520 9_
- $a Head and neck squamous cell carcinomas (HNSCC) can be induced by smoking or alcohol consumption, but a growing part of cases relate to a persistent high-risk papillomavirus (HPV) infection. Viral etiology has a beneficial impact on the prognosis, which may be explained by a specific immune response. Tumor associated macrophages (TAMs) represent the main immune population of the tumor microenvironment with a controversial influence on the prognosis. In this study, the level, phenotype, and spatial distribution of TAMs were evaluated, and the expression of TAM-associated markers was compared in HPV positive (HPV+) and HPV negative (HPV-) tumors. Seventy-three formalin and embedded in paraffin (FFPE) tumor specimens were examined using multispectral immunohistochemistry for the detection of TAM subpopulations in the tumor parenchyma and stroma. Moreover, the mRNA expression of TAM markers was evaluated using RT-qPCR. Results were compared with respect to tumor etiology, and the prognostic significance was evaluated. In HPV- tumors, we observed more pro-tumorigenic M2 in the stroma and a non-macrophage arginase 1 (ARG1)-expressing population in both compartments. Moreover, higher mRNA expression of M2 markers-cluster of differentiation 163 (CD163), ARG1, and prostaglandin-endoperoxide synthase 2 (PTGS2)-was detected in HPV- patients, and of M1 marker nitric oxide synthase 2 (NOS2) in HPV+ group. The expression of ARG1 mRNA was revealed as a negative prognostic factor for overall survival of HNSCC patients.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Šmahelová, Jana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 252 50 Vestec, Czech Republic
- 700 1_
- $a Dalewská, Natálie $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 252 50 Vestec, Czech Republic
- 700 1_
- $a Grega, Marek $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University, 150 06 Prague, Czech Republic
- 700 1_
- $a Vencálek, Ondřej $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science of the Palacky University in Olomouc, 771 46 Olomouc, Czech Republic
- 700 1_
- $a Šmahel, Michal $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 252 50 Vestec, Czech Republic
- 700 1_
- $a Nunvář, Jaroslav $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 252 50 Vestec, Czech Republic
- 700 1_
- $a Klozar, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, 1st Faculty of Medicine, Charles University, University Hospital Motol, 150 06 Prague, Czech Republic
- 700 1_
- $a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, 252 50 Vestec, Czech Republic
- 773 0_
- $w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 11, č. 4 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33807310 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210726 $b ABA008
- 991 __
- $a 20210729104114 $b ABA008
- 999 __
- $a ind $b bmc $g 1676516 $s 1138494
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 4 $e 20210331 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
- GRA __
- $a CZ.1.05/2.1.00/19.0400 $p European Regional Development Fund
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000785 $p European Regional Development Fund
- GRA __
- $a 17-28055A $p Czech Health Research Council
- GRA __
- $a 1502118 $p Charles University Grant Agency
- GRA __
- $a 260568 $p Charles University Specific University Research
- LZP __
- $a Pubmed-20210726
